Literature DB >> 3351842

Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus.

C E Weidmann1, D J Wallace, J B Peter, P J Knight, M B Bear, J R Klinenberg.   

Abstract

We evaluated the clinical relevance of 6 antiphospholipid antibodies including cardiolipin and their IgG, IgM and IgA isotypes in 92 patients with systemic lupus erythematosus (SLE). Antiphospholipid antibodies generally had significant associations with thrombocytopenia and a history of false-positive syphilis serologies. In 4 of 6 antiphospholipid antibodies, an inverse association with renal disease was observed. Antiphospholipid antibodies may moderate or protect against renal disease, or this may reflect the high doses of corticosteroids and cytotoxic drugs received by this group. Further studies are needed to determine how many antibody families cause these activities and to elucidate whether certain SLE subgroups possess differing specificities for each of the phospholipids.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3351842

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

1.  Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.

Authors:  R Cervera; J Font; A López-Soto; F Casals; L Pallarés; A Bové; M Ingelmo; A Urbano-Márquez
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

2.  Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study.

Authors:  H J Out; P G de Groot; P Hasselaar; M dan Vliet; R H Derksen
Journal:  Ann Rheum Dis       Date:  1989-12       Impact factor: 19.103

3.  Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.

Authors:  M Samarkos; K A Davies; C Gordon; S Loizou
Journal:  Clin Rheumatol       Date:  2005-08-10       Impact factor: 2.980

4.  Reactivity patterns of anti-phospholipid antibodies in systemic lupus erythematosus sera in relation to erythrocyte binding and complement activation.

Authors:  J Arvieux; B Roussel; D Ponard; M G Colomb
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

Review 5.  The 'antiphospholipid syndrome' and the 'lupus anticoagulant'.

Authors:  J S Cameron; G Frampton
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

6.  Antiphospholipid antibodies in systemic lupus erythematosus: clinical and laboratory associations in 111 patients.

Authors:  Y Wang; L Schrieber; M G Cohen; L Furphy; J Webb; T Chivers; K M Pollard
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

7.  Nodular regenerative hyperplasia of the liver and coeliac disease: potential role of IgA anticardiolipin antibody.

Authors:  A Austin; E Campbell; P Lane; E Elias
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

8.  Utility of antiphosphatidylserine/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus.

Authors:  Ehtisham Akhter; Zakera Shums; Gary L Norman; Walter Binder; Hong Fang; Michelle Petri
Journal:  J Rheumatol       Date:  2013-02-01       Impact factor: 4.666

9.  Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?

Authors:  A Ghirardello; A Doria; A Ruffatti; A M Rigoli; P Vesco; A Calligaro; P F Gambari
Journal:  Ann Rheum Dis       Date:  1994-02       Impact factor: 19.103

10.  A study of immune responses to myelin and cardiolipin in patients with systemic lupus erythematosus (SLE).

Authors:  A Khalili; R C Cooper
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.